AG-24322 Terminated Phase 1 Trials for Neoplasm / Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00147485A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer